INC Research to merge with private-equity owned InVentiv Health in all-stock deal
May 10, 2017 at 07:27 AM EDT
Deal values InVentiv at $4.6 billion, including debt, and will create a large biopharmaceutical outsourcing provider.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|